Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 study evaluating subcutaneous decitabine in adults with low- or intermediate-1 risk myelodysplastic syndromes has completed with pos…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS. [Phase 4]
A Phase 4 trial comparing decitabine with azacitidine in intermediate- or high-risk myelodysplastic syndromes was terminated, with results p…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation [Phase 1]
Phase 1 study of a partially HLA-matched irradiated allogeneic cellular therapy given after reduced-intensity total body irradiation; the tr…
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial evaluating lenalidomide plus decitabine in high-grade myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings [NA]
A completed clinical trial update describing USCOM readings in patients with hematologic malignancies including leukemia, lymphoma, multiple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: SCRI Tissue Testing Registry
This trial update indicates the SCRI Tissue Testing Registry study has been terminated; it involved patients with melanoma, myelodysplastic …
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of Obatoclax Mesylate (GX15-070MS) for treating Myelodysplastic Syndromes has completed…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Phase 2, Phase 3]
This clinical trial update notes a completed Phase 2/Phase 3 study evaluating combination chemotherapy with or without gemtuzumab ozogamicin…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial evaluating romiplostim for thrombocytopenia in patients with low- or intermediate-1 risk myelodysplastic syndrome has complete…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
The trial evaluating reduced-intensity umbilical cord blood transplantation in adults with advanced hematopoietic malignancies has been term…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
This clinical trial update notes the completion of an unrelated donor stem cell transplantation study in adults with hematopoietic disorders…
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome [Phase 2]
This is a Phase 2 clinical trial update reporting results for lenalidomide (Revlimid) in patients with acute myeloid leukemia and myelodyspl…
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update evaluating donor stem cell transplant for hematologic cancers, including leukemia and lymphoma, with results p…
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Low Dose Melphalan and Bortezomib for AML and High-Risk MDS [NA]
Clinical trial of low-dose melphalan and bortezomib for acute myeloid leukemia and high-risk myelodysplastic syndromes has completed with re…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia [Phase 2]
Phase 2 study of VNP40101M in acute myeloid leukemia and high-risk myelodysplastic syndromes has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: 3-AP and Cytarabine in Treating Patients With Hematologic Cancer [Phase 1]
The document reports the completion of a Phase 1 trial evaluating 3-AP with cytarabine in patients with leukemia and myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial of VNP40101M in combination with Cytarabine for hematologic malignancies (leukemia and myelodysplastic syndromes) has complete…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial evaluating VNP40101M in relapsed or refractory leukemia or myelodysplastic syndromes; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS [Phase 2]
Phase 2 clinical trial evaluating the combination of clofarabine and cytarabine (Ara-C) for relapsed acute myeloid leukemia and untreated my…
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) [NA]
Clinical trial update evaluating long-term dosing safety of romiplostim (AMG 531) in thrombocytopenic subjects with myelodysplastic syndrome…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease [Phase 1]
Phase 1 clinical trial evaluating infusion of genetically modified T cells in post-transplant patients with relapsed disease has completed. …
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [Phase 2]
A phase 2 study of cediranib maleate in adults with relapsed/refractory or untreated acute myeloid leukemia or high-risk myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [Phase 2, Phase 3]
This document summarizes Phase 2 and Phase 3 clinical trials evaluating a treatment aimed at preventing graft-versus-host disease in patient…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]
This entry updates a Phase 2 chemotherapy trial for newly diagnosed acute myeloid leukemia, chronic myeloid leukemia, and myelodysplastic sy…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Decitabine, Cytarabine, GCSF for Refractory AML/MDS [Phase 2]
Phase 2 trial of decitabine, cytarabine, and GCSF for refractory AML/MDS was terminated with results posted.